A citation-based method for searching scientific literature

John Rensselaer van Nagell, Rachel Ware Miller, Christopher P DeSimone, Frederick R Ueland, Iwona Podzielinski, Scott T Goodrich, Jeff W Elder, Bin Huang, Richard J Kryscio, Edward John Pavlik. Obstet Gynecol 2011
Times Cited: 63







List of co-cited articles
549 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
712
76

A randomized study of screening for ovarian cancer: a multicenter study in Japan.
H Kobayashi, Y Yamada, T Sado, M Sakata, S Yoshida, R Kawaguchi, S Kanayama, H Shigetomi, S Haruta, Y Tsuji,[...]. Int J Gynecol Cancer 2008
149
66

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes,[...]. Lancet Oncol 2009
501
55

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
472
55

Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
John R van Nagell, Paul D DePriest, Frederick R Ueland, Christopher P DeSimone, Amy L Cooper, J Matt McDonald, Edward J Pavlik, Richard J Kryscio. Cancer 2007
130
26

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.
Edward J Pavlik, Frederick R Ueland, Rachel W Miller, Jessalyn M Ubellacker, Christopher P DeSimone, Jeffrey Elder, John Hoff, Lauren Baldwin, Richard J Kryscio, John R van Nagell. Obstet Gynecol 2013
48
31

Results from four rounds of ovarian cancer screening in a randomized trial.
Edward Partridge, Aimee R Kreimer, Robert T Greenlee, Craig Williams, Jian-Lun Xu, Timothy R Church, Bruce Kessel, Christine C Johnson, Joel L Weissfeld, Claudine Isaacs,[...]. Obstet Gynecol 2009
173
20

The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Christopher P Crum, Ronny Drapkin, Alexander Miron, Tan A Ince, Michael Muto, David W Kindelberger, Yonghee Lee. Curr Opin Obstet Gynecol 2007
324
19

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
Saundra S Buys, Edward Partridge, Mark H Greene, Philip C Prorok, Douglas Reding, Thomas L Riley, Patricia Hartge, Richard M Fagerstrom, Lawrence R Ragard, David Chia,[...]. Am J Obstet Gynecol 2005
212
19


Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
A Sharma, S Apostolidou, M Burnell, S Campbell, M Habib, A Gentry-Maharaj, N Amso, M W Seif, G Fletcher, N Singh,[...]. Ultrasound Obstet Gynecol 2012
50
22


Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
194
15

The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention".
Christopher P Crum, Frank D McKeon, Wa Xian. Clin Obstet Gynecol 2012
49
20

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Adam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, Philip Badman, Susan Philpott, Jessica Mozersky, Richard Hadwin, Fay H Cafferty, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2013
87
15

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
15

Simple ultrasound-based rules for the diagnosis of ovarian cancer.
D Timmerman, A C Testa, T Bourne, L Ameye, D Jurkovic, C Van Holsbeke, D Paladini, B Van Calster, I Vergote, S Van Huffel,[...]. Ultrasound Obstet Gynecol 2008
249
14

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Steven J Skates, Usha Menon, Nicola MacDonald, Adam N Rosenthal, David H Oram, Robert C Knapp, Ian J Jacobs. J Clin Oncol 2003
155
14

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Usha Menon, Steven J Skates, Sara Lewis, Adam N Rosenthal, Barnaby Rufford, Karen Sibley, Nicola Macdonald, Anne Dawnay, Arjun Jeyarajah, Robert C Bast,[...]. J Clin Oncol 2005
150
14

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
707
14

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015
116
14

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
555
14

Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).
J Barrett, V Jenkins, V Farewell, U Menon, I Jacobs, J Kilkerr, A Ryan, C Langridge, L Fallowfield. BJOG 2014
31
29

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
72
14

Screening for ovarian cancer: a pilot randomised controlled trial.
I J Jacobs, S J Skates, N MacDonald, U Menon, A N Rosenthal, A P Davies, R Woolas, A R Jeyarajah, K Sibley, D G Lowe,[...]. Lancet 1999
371
12




A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
12

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
Nienke M van der Velde, Marian J E Mourits, HenriĆ«tte J G Arts, Jacob de Vries, Beike K Leegte, Grieteke Dijkhuis, Jan C Oosterwijk, Geertruida H de Bock. Int J Cancer 2009
83
12



Early detection of ovarian tumors using ultrasound.
Edward J Pavlik, John R van Nagell. Womens Health (Lond) 2013
15
53

Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.
Susan C Modesitt, Edward J Pavlik, Frederick R Ueland, Paul D DePriest, R J Kryscio, J R van Nagell. Obstet Gynecol 2003
124
12


Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Antonia C Testa, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser,[...]. BMJ 2014
149
12

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.
Jeffrey W Elder, Edward J Pavlik, Ashleigh Long, Rachel W Miller, Christopher P DeSimone, John T Hoff, Walker R Ueland, Richard J Kryscio, John R van Nagell, Frederick R Ueland. Gynecol Oncol 2014
20
40


A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
469
11

Predictive value of symptoms for early detection of ovarian cancer.
Mary Anne Rossing, Kristine G Wicklund, Kara L Cushing-Haugen, Noel S Weiss. J Natl Cancer Inst 2010
90
11

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Diane Stirling, D Gareth R Evans, Gabriella Pichert, Andrew Shenton, Elaine N Kirk, Sylvia Rimmer, C Michael Steel, Sheila Lawson, R M Camille Busby-Earle, Jane Walker,[...]. J Clin Oncol 2005
109
11

Development of an ovarian cancer symptom index: possibilities for earlier detection.
Barbara A Goff, Lynn S Mandel, Charles W Drescher, Nicole Urban, Shirley Gough, Kristi M Schurman, Joshua Patras, Barry S Mahony, M Robyn Andersen. Cancer 2007
227
11

Ovarian cancer screening.
John R van Nagell, Edward John Pavlik. Clin Obstet Gynecol 2012
21
33

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Mirjam J A Engelen, Henrike E Kos, Pax H B Willemse, Jan G Aalders, Elisabeth G E de Vries, Michael Schaapveld, Renee Otter, Ate G J van der Zee. Cancer 2006
188
11

Ovarian cancer screening--current status, future directions.
Usha Menon, Michelle Griffin, Aleksandra Gentry-Maharaj. Gynecol Oncol 2014
86
11

Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women.
John Rensselaer van Nagell, Rachel Ware Miller. Obstet Gynecol 2016
18
38

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Paul F Pinsky, Kelly Yu, Barnett S Kramer, Amanda Black, Saundra S Buys, Edward Partridge, John Gohagan, Christine D Berg, Philip C Prorok. Gynecol Oncol 2016
55
12

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
9

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
Lucy Gilbert, Olga Basso, John Sampalis, Igor Karp, Claudia Martins, Jing Feng, Sabrina Piedimonte, Louise Quintal, Agnihotram V Ramanakumar, Janet Takefman,[...]. Lancet Oncol 2012
92
9

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
469
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.